An addiction psychiatry clinic evaluates a 29-year-old male patient who is seeking pharmacological support to maintain abstinence from heroin. The patient states he was discharged from a short-term inpatient detoxification facility 10 days ago and has not used any illicit substances since. Physical examination reveals normal pupillary size, absence of piloerection, and a resting heart rate of 72/min. The physician and patient agree to proceed with an opioid antagonist therapy to reduce the risk of relapse. Arrange the following steps in the most appropriate chronological sequence for safely initiating this patient on long-acting injectable naltrexone.
- 1Obtain a comprehensive urine toxicology screen to objectively verify self-reported abstinence.
- 2Administer a naloxone challenge test to confirm the absence of physiological opioid dependence.
- 3Prescribe a short trial of oral naltrexone to evaluate medication tolerability.
- 4Administer the extended-release intramuscular naltrexone injection.
Answer
The correct sequence is to first verify abstinence with a urine toxicology screen, followed by a naloxone challenge test to rule out physical dependence, then a trial of oral naltrexone for tolerability, and finally the administration of extended-release intramuscular naltrexone.
The initiation of naltrexone therapy requires a strict protocol to ensure patient safety and prevent precipitated withdrawal. The correct sequence is: 1) Objectively verify the required 7 to 14-day abstinence period with a urine drug screen. 2) Perform a naloxone challenge test to ensure the complete resolution of physical dependence (as urine screens may miss some synthetic opioids). 3) Provide a brief oral naltrexone trial to ensure medication tolerability. 4) Administer the long-acting intramuscular formulation for maintenance.
Step-by-Step Solution
Key Concept
Initiation protocol for naltrexone maintenance in Opioid Use Disorder